We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.1B
AUM Growth
+$13.3M
Cap. Flow
-$24.2M
Cap. Flow %
-2.19%
Top 10 Hldgs %
27.52%
Holding
243
New
37
Increased
59
Reduced
88
Closed
42

Top Buys

Rank Stock Value
1
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$11.5M
2
KR icon
Kroger
KR
+$11M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.23M
4
T icon
AT&T
T
+$7.54M
5
ICE icon
Intercontinental Exchange
ICE
+$6.16M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$16.6M
2
MET icon
MetLife
MET
+$12.3M
3
TROW icon
T. Rowe Price
TROW
+$11M
4
SCHW
Charles Schwab
SCHW
+$10.8M
5
BLK icon
Blackrock
BLK
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.28%
2 Consumer Staples 11.92%
3 Technology 10.82%
4 Financials 9.16%
5 Energy 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
151
Jazz Pharmaceuticals
JAZZ
$16.7B
$385K 0.03%
+2,700
New +$363K
MNRO icon
152
Monro
MNRO
$398M
$384K 0.03%
4,500
-1,472
-25% -$123K
JNJ icon
153
Johnson & Johnson
JNJ
$625B
$383K 0.03%
2,753
-341
-11% -$47.2K
BIG
154
DELISTED
Big Lots, Inc.
BIG
$383K 0.03%
13,400
+2,907
+28% +$97.1K
CNA icon
155
CNA Financial
CNA
$14.1B
$381K 0.03%
8,100
-1,960
-19% -$89.2K
HUBB icon
156
Hubbell
HUBB
$27.2B
$378K 0.03%
2,900
-640
-18% -$79K
EMN icon
157
Eastman Chemical
EMN
$8.42B
$374K 0.03%
4,800
-5,558
-54% -$422K
SLGN icon
158
Silgan Holdings
SLGN
$4.41B
$373K 0.03%
12,200
-22,961
-65% -$685K
MASI
159
DELISTED
Masimo
MASI
$372K 0.03%
2,500
-638
-20% -$87.5K
SSD icon
160
Simpson Manufacturing
SSD
$8.16B
$372K 0.03%
5,600
-889
-14% -$56.8K
AVY icon
161
Avery Dennison
AVY
$13.4B
$370K 0.03%
3,200
-7,823
-71% -$856K
PFG icon
162
Principal Financial Group
PFG
$24.3B
$365K 0.03%
6,300
-3,403
-35% -$188K
PDCO
163
DELISTED
Patterson Companies, Inc.
PDCO
$364K 0.03%
15,900
+1,984
+14% +$44.1K
WST icon
164
West Pharmaceutical
WST
$24.9B
$363K 0.03%
2,900
+184
+7% +$21.7K
RGA icon
165
Reinsurance Group of America
RGA
$16.1B
$359K 0.03%
2,300
-1,403
-38% -$210K
SON icon
166
Sonoco
SON
$5.74B
$359K 0.03%
+5,500
New +$347K
MTB icon
167
M&T Bank
MTB
$36.2B
$357K 0.03%
+2,100
New +$348K
COR icon
168
Cencora
COR
$61.2B
$350K 0.03%
4,100
+1,436
+54% +$114K
GL icon
169
Globe Life
GL
$14.3B
$349K 0.03%
3,900
-2,537
-39% -$221K
MCK icon
170
McKesson
MCK
$101B
$349K 0.03%
+2,600
New +$324K
THG icon
171
Hanover Insurance
THG
$7.98B
$346K 0.03%
2,700
-2,237
-45% -$272K
SIGI icon
172
Selective Insurance
SIGI
$5.73B
$344K 0.03%
+4,600
New +$328K
UTHR icon
173
United Therapeutics
UTHR
$23.1B
$343K 0.03%
4,400
+928
+27% +$86.8K
BXMT icon
174
Blackstone Mortgage Trust
BXMT
$2.38B
– –
0
– –
HMN icon
175
Horace Mann Educators
HMN
$2.11B
$342K 0.03%
+8,500
New +$334K
5 6
7
8 9

Similar funds

PCG
Prosperity Consulting Group Owings Mills, Maryland $2.25B AUM 15.87% 1-Year Est. Return
PC
Port Capital Chicago, Illinois $2.25B AUM 13.28% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
SEGHC
Saudi Electronic Games Holding Co Riyadh $2.25B AUM
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
NP
NS Partners London, United Kingdom $2.23B AUM 20.03% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

GW Henssler & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, GW Henssler & Associates held 243 positions worth $1.1B, up 1.2% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GW Henssler & Associates's Q2 2019 filing shows 37 new, 59 increased, 88 reduced and 42 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M. The largest sale was Celgene Corp, an estimated $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Consumer Staples and Technology.

  • GW Henssler & Associates's largest Q2 2019 buy was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M.
  • GW Henssler & Associates added most to State Street Utilities Select Sector SPDR ETF in Q2 2019, an estimated $11.5M increase.
  • GW Henssler & Associates's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $16.6M.
  • GW Henssler & Associates fully exited NIC Inc in Q2 2019, selling an estimated $1.2M.
  • GW Henssler & Associates's ten largest holdings make up 28% of its $1.1B portfolio in Q2 2019.
  • GW Henssler & Associates opened 37 new positions and closed 42 in Q2 2019.
  • GW Henssler & Associates's portfolio value rose 1.2% quarter-over-quarter to $1.1B.

Based on GW Henssler & Associates's 13F filing for Q2 2019, filed 5 Aug 2019.